Pharmacy Website
Clinic Website

Intelligence » Arthritis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

Gilead earns needed trial win as arthritis drug succeeds in 2 studies

Friday, March 29, 2019 -- Filgotinib, a JAK inhibitor that Gilead's bet heavily on, met the goals of two large Phase 3 trials. But its road through the FDA remains uncertain.

AbbVie Announces First Regulatory Approval of SKYRIZI™ (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan

Tuesday, March 26, 2019 -- (MENAFN - PR Newswire) NORTH CHICAGO, Ill., March 26, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV ), a research-based global biopharmaceutical company, today announced that the Japane...

Researchers report new regenerative medicine approach for treating osteoarthritis of the knee

Monday, March 25, 2019 -- Researchers at Tokai University report in the journal npj Regenerative Medicine a regenerative medicine approach for treating osteoarthritis of the knee.

First Treatment for Non-Radiographic Axial Spondyloarthritis Granted FDA Approval

Thursday, March 28, 2019 -- With this approval, certolizumab pegol becomes the first FDA-approved therapy for this type of axSpA, filling an unmet clinical need for treatment options, according to the release.